With the ASCENT project ending on 31 December 2022, the ASCENT Philippines team held separate meetings with key partners in the Philippines to prime them for the scale-up of DAT implementation.

In March 2022, Richard Clores, the nurse who attends to drug-resistant tuberculosis (DRTB) patients at the Bulacan Medical Center PMDT satellite treatment center in Bulacan province, Philippines, enrolled five patients in the use of digital adherence technology (DAT).

Dr. Jakob Simmank, the head of the health section of Die Zeit, an online newspaper in Hamburg, Germany, is preparing an article on the fight against tuberculosis (TB), including the use of digital adherence technology (DAT) for TB treatment.

Bulacan, Philippines celebrated World TB Day 2022 with Governor Daniel Fernando signing the Memorandum of understanding (MOU) between KNCV Tuberculosis Foundation and the Department of Health of the Philippines.

ASCENT Philippines gathered drug-resistant tuberculosis (DRTB) patients to guide them in their use of digital adherence technology (DAT), in particular video-supported treatment (VOT) using the SureAdhere app and the evriMED smart pillbox.

During a recent virtual meeting, key tuberculosis (TB) partners jointly reviewed and updated the ASCENT differentiated care pathway for the use of digital adherence technologies (DAT) to support TB patients taking their medication.

ASCENT Philippines distributed all necessary digital adherence technologies intervention facilities in Bulacan and Pampanga. This enabled the run-in phase to start: all facilities are now enrolling patients on these innovative digital technologies.

Randomization events were held in the Bulacan and Pampanga provinces in the Philippines to identify the health facilities which will use digital adherence technologies as part of the ASCENT project.

Angelito: “Thanks to nurse Anton’s warm support, and my family’s constant encouragement, I didn’t give up. And thanks, too, for 99DOTS.